Skip to main content Accessibility help
×
×
Home

Louse-borne relapsing fever (Borrelia recurrentis infection)

  • David A. Warrell (a1)
Abstract

Louse-borne relapsing fever (LBRF) is an epidemic disease with a fascinating history from Hippocrates’ times, through the 6th century ‘Yellow Plague’, to epidemics in Ireland, Scotland and England in the 19th century and two large Afro-Middle Eastern pandemics in the 20th century. An endemic focus persists in Ethiopia and adjacent territories in the Horn of Africa. Since 2015, awareness of LBRF in Europe, as a re-emerging disease, has been increased dramatically by the discovery of this infection in dozens of refugees arriving from Africa.

The causative spirochaete, Borrelia recurrentis, has a genome so similar to B. duttonii and B. crocidurae (causes of East and West African tick-borne relapsing fever), that they are now regarded as merely ecotypes of a single genomospecies. Transmission is confined to the human body louse Pediculus humanus corporis, and, perhaps, the head louse P. humanus capitis, although the latter has not been proved. Infection is by inoculation of louse coelomic fluid or faeces by scratching. Nosocomial infections are possible from contamination by infected blood. Between blood meals, body lice live in clothing until the host's body temperature rises or falls, when they seek a new abode.

The most distinctive feature of LBRF, the relapse phenomenon, is attributable to antigenic variation of borrelial outer-membrane lipoprotein. High fever, rigors, headache, pain and prostration start abruptly, 2–18 days after infection. Petechial rash, epistaxis, jaundice, hepatosplenomegaly and liver dysfunction are common. Severe features include hyperpyrexia, shock, myocarditis causing acute pulmonary oedema, acute respiratory distress syndrome, cerebral or gastrointestinal bleeding, ruptured spleen, hepatic failure, Jarisch–Herxheimer reactions (J-HR) and opportunistic typhoid or other complicating bacterial infections. Pregnant women are at high risk of aborting and perinatal mortality is high.

Rapid diagnosis is by microscopy of blood films, but polymerase chain reaction is used increasingly for species diagnosis. Severe falciparum malaria and leptospirosis are urgent differential diagnoses in residents and travellers from appropriate geographical regions.

High untreated case-fatality, exceeding 40% in some historic epidemics, can be reduced to less than 5% by antibiotic treatment, but elimination of spirochaetaemia is often accompanied by a severe J-HR.

Epidemics are controlled by sterilising clothing to eliminate lice, using pediculicides and by improving personal hygiene.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Louse-borne relapsing fever (Borrelia recurrentis infection)
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Louse-borne relapsing fever (Borrelia recurrentis infection)
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Louse-borne relapsing fever (Borrelia recurrentis infection)
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Corresponding author
Author for correspondence: David A. Warrell, E-mail: david.warrell@ndm.ox.ac.uk
References
Hide All
1.Felsenfeld, O (1971) Borrelia: Strains, Vectors, Human and Animal Borreliosis. St. Louis, Missouri, USA: Green, 180.
2.Cutler, SJ et al. (1997) Borrelia recurrentis characterization and comparison with relapsing-fever, Lyme-associated, and other Borrelia spp. International Journal of Systematic Bacteriology 47, 958968.
3.Larsson, C et al. (2009) A novel animal model of Borrelia recurrentis louse-borne relapsing fever borreliosis using immunodeficient mice. PLoS Neglected Tropical Diseases 3, e522.
4.Cutler, SJ et al. (1994) Successful in-vitro cultivation of Borrelia recurrentis. Lancet 343, 242.
5.Marosevic, D et al. (2017) First insights in the variability of Borrelia recurrentis genomes. PLoS Neglected Tropical Diseases 11, e0005865.
6.Ružić-Sabljić, E et al. (2017) Comparison of MKP and BSK-H media for the cultivation and isolation of Borrelia burgdorferi sensu lato. PLoS ONE 12, e0171622.
7.Lescot, M et al. (2008) The genome of Borrelia recurrentis, the agent of deadly louse-borne relapsing fever, is a degraded subset of tick-borne Borrelia duttonii. PLoS Genetics 4, e1000185.
8.Elbir, H et al. (2014) African relapsing fever Borreliae genomospecies revealed by comparative genomics. Frontiers in Public Health. 2, 43.
9.Amanzougaghene, N et al. (2016) Head lice of pygmies reveal the presence of relapsing fever Borreliae in the Republic of Congo. PLoS Neglected Tropical Diseases 10, e0005142.
10.Sholdt, LL, Holloway, ML and Fronk, WD. The epidemiology of human pediculosis in Ethiopia. Special Publication, Navy Disease Vector Ecology and Control Center, Naval Air Station, Jacksonville, Florida 32212 (Fig. 26, page 76), pp. 159.
11.Sangaré, AK, Doumbo, OK and Raoult, D (2016) Management and treatment of human lice. Biomed Research International 2016, 8962685.
12.Bryceson, ADM et al. (1970) Louse-borne relapsing fever. A clinical and laboratory study of 62 cases in Ethiopia and a reconsideration of the literature. Quarterly Journal of Medicine 39, 129170.
13.Larsson, C et al. (2006) Complications of pregnancy and transplacental transmission of relapsing-fever borreliosis. Journal of Infectious Diseases 194, 13671374.
14.Fuchs, PC and Oyama, AA (1969) Neonatal relapsing fever due to transplacental transmission of Borrelia. Journal of the American Medical Association 208, 690692.
15.Lloyd, GER (ed). (1983) Hippocratic Writings (Translated by Chadwick J and Mann WN). London: Penguin Books, 9598.
16.MacArthur, W (1957) Historical notes on some epidemic diseases associated with jaundice. British Medical Bulletin 13, 146149.
17.Guellil, M et al. (2018) Genomic blueprint of a relapsing fever pathogen in 15th century Scandinavia. Proceedings of the National Academy of Sciences U S A 115, 1042210427.
18.Rutty, J (1770) A Chronological History of the Weather and Seasons, and of the Prevailing Diseases in Dublin. London: Robinson and Roberts.
19.Craigie, D (1843) Notice of a febrile disorder which has prevailed at Edinburgh during the Summer of 1843. Edinburgh Medical and Surgical Journal 60, 410418.
20.Henderson, W (1844) On some of the characters which distinguish the fever at present epidemic from typhus. Edinburgh Medical and Surgical Journal 61, 201225.
21.Murchison, C (1862) A Treatise on the Continued Fevers of Great Britain. London, Parker, and Bourn, 290409.
22.Wright, DJ and Maria, B (2011) Ich bin ein Berliner. The contributions of early British colonial and German scientists to the elucidation of the nature of spirochaetes. Clinical Microbiology and Infection 17, 484486.
23.Mackie, FP (1907) The part played by Pediculus corporis in the transmission of relapsing fever. British Medical Journal 2, 17061709.
24.Sparrow, H (1958) Étude du foyer Éthiopien de fièvre récurrente. Bulletin de l'organisation. mondiale de la Santé 19, 673710.
25.ProMED-mail (International Society for Infectious Diseases). Borreliosis, relapsing fever – Sudan (South). ProMED-mail 1999; 19990511.0767; http://www.promedmail.org. Accessed 27 Oct 2018.
26.Valdizan, M, Lopez, J and Delgado, A (1985) Borreliosis en las alturas del Peru. Diagnóstico (Peru) 15, 913.
27.Raoult, D et al. (1999) Survey of three bacterial louse-associated diseases among rural Andean communities in Peru: prevalence of epidemic typhus, trench fever, and relapsing fever. Clinical Infectious Diseases 29, 434436.
28.Ciervo, A et al. (2016) Louseborne relapsing fever in young migrants, Sicily, Italy, July-September 2015. Emerging Infectious Diseases 22, 152153.
29.Hoch, M et al. (2015) Louse-borne relapsing fever (Borrelia recurrentis) diagnosed in 15 refugees from northeast Africa: epidemiology and preventive control measures, Bavaria, Germany, July to October 2015. Eurosurveillance 20(42), 15.
30.European Centre for Disease Prevention and Control. Louse-borne relapsing fever in the EU 17 November 2015 Stockholm: ECDC; 2015; http://ecdc.europa.eu/en/publications/publications/louse-borne-relapsing-fever-in-eu-rapid-risk-assessment-17-nov-15.pdf accessed 27-20-18.
31.Antinori, S et al. (2016) Louse-borne relapsing fever among East African refugees in Europe. Travel Medicine and Infectious Diseases 14, 513514.
32.Hytönen, J et al. (2017) Louse-borne relapsing fever in Finland in two asylum seekers from Somalia. APMIS Acta Pathologica, Microbiologica, et Immunologica Scandinavica 125, 5962.
33.Ackermann, N et al. (2018) Screening for infectious diseases among newly arrived asylum seekers, Bavaria, Germany, 2015. Eurosurveillance 23, 111.
34.Isenring, E et al. (2018) Infectious disease profiles of Syrian and Eritrean migrants presenting in Europe: a systematic review. Travel Medicine and Infectious Diseases 25, 6576.
35.Grecchi, C et al. (2017) Louse-borne relapsing fever in a refugee from Mali. Infection 45, 373376.
36.Barbour, AG and Hayes, SF (1986) Biology of Borrelia species. Microbiological Reviews 50, 381400.
37.Vidal, V et al. (1998) Variable major lipoprotein is a principal TNF-inducing factor of louse-borne relapsing fever. Nature Medicine 4, 14161420.
38.Grosskinsky, S et al. (2010) Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis. PLoS Neglected Tropical Diseases 4, e698.
39.Guo, BP et al. (2009) Relapsing fever Borrelia binds to neolacto glycans and mediates rosetting of human erythrocytes. Proceedings of the National Academy of Sciences U S A 106, 1928019285.
40.Negussie, Y et al. (1992) Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch–Herxheimer reaction of relapsing fever. Journal of Experimental Medicine 175, 12071212.
41.Coxon, RE et al. (1997) The effect of antibody against TNF alpha on cytokine response in Jarisch–Herxheimer reactions of louse-borne relapsing fever. Quarterly Journal of Medicine 90, 213221.
42.Butler, T (2017) The Jarisch–Herxheimer reaction after antibiotic treatment of spirochetal infections: a review of recent cases and our understanding of pathogenesis. American Journal of Tropical Medicine and Hygiene 96, 4652.
43.Warrell, DA et al. (1970) Cardiorespiratory disturbances associated with infective fever in man: studies of Ethiopian louse-borne relapsing fever. Clinical Science 39, 123145.
44.Judge, DM et al. (1974) D Louse-borne relapsing fever in man. Archives of Pathology 97, 136170.
45.Anderson, TR and Zimmerman, LE (1955) Relapsing fever in Korea; a clinicopathologic study of eleven fatal cases with special attention to association with Salmonella infections. American Journal of Pathology 31, 10831109.
46.Salih, SY et al. (1977) Louse-borne relapsing fever: I. A clinical and laboratory study of 363 cases in the Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene 71, 4348.
47.Perine, PL et al. (1992) A clinico-epidemiological study of epidemic typhus in Africa. Clinical Infectious Diseases 14, 11491158.
48.Antinori, S et al. (2017) Diagnosis of Louse-Borne relapsing fever despite negative microscopy in two asylum seekers from Eastern Africa. American Journal of Tropical Medicine and Hygiene 97, 16691672.
49.Ramos, JM et al. (2004) Characteristics of louse-borne relapsing fever in Ethiopian children and adults. Annals of Tropical Medicine and Parasitology 98, 191196.
50.Ramos, JM et al. (2009) Louse-borne relapsing fever in Ethiopian children: experience of a rural hospital. Tropical Doctor 39, 3436.
51.Borgnolo, G et al. (1993) Louse-borne relapsing fever in Ethiopian children: a clinical study. Annals of Tropical Paediatrics 13, 165171.
52.Nordmann, T et al. (2018) Outbreak of louse-borne relapsing fever among urban dwellers in Arsi zone, central Ethiopia, from July to November 2016. American Journal of Tropical Medicine and Hygiene 98, 15991602.
53.Parry, EH et al. (1970) Some effects of louse-borne relapsing fever on the function of the heart. American Journal of Medicine 49, 472479.
54.Hovette, P et al. (2001) Value of Quantitative Buffy Coat (QBC) in borreliasis-malaria co-infection. Médecine Tropicale (Marseille) 61, 196197.
55.Larsson, C and Bergström, S (2008) A novel and simple method for laboratory diagnosis of relapsing fever borreliosis. Open Microbiology Journal 2, 1012.
56.Berger, SA and David, L (2005) Pseudo-borreliosis in patients with malaria. American Journal of Tropical Medicine and Hygiene 73, 207209.
57.Elbir, H et al. (2013) Multiplex real-time PCR diagnostic of relapsing fevers in Africa. PLoS Neglected Tropical Diseases 7, e2042.
58.Sokhna, C et al. (2013) Point-of-care laboratory of pathogen diagnosis in rural Senegal. PLoS Neglected Tropical Diseases 7, e1999.
59.Porcella, S et al. (2000) Sero-diagnosis of louse-borne relapsing fever with glycerol phosphodiesterase (GlpQ) from Borrelia recurrentis. Journal of Clinical Microbiology 38, 35613571.
60.Fotso Fotso, A et al. (2016) Monoclonal antibodies for the diagnosis of Borrelia crocidurae. American Journal of Tropical Medicine and Hygiene 94, 6167.
61.Cutuli, SL et al. (2017) Lice, rodents, and many hopes: a rare disease in a young refugee. Critical Care 21, 81.
62.Perine, PL and Teklu, B (1983) Antibiotic treatment of louse-borne relapsing fever in Ethiopia: a report of 377 cases. American Journal of Tropical Medicine and Hygiene 32, 10962000.
63.Warrell, DA et al. (1983) Pathophysiology and immunology of the Jarisch–Herxheimer-like reaction in louse-borne relapsing fever: comparison of tetracycline and slow-release penicillin. Journal of Infectious Diseases 147, 898909.
64.Seboxa, T and Rahlenbeck, S (1995) Treatment of louse-borne relapsing fever with low dose penicillin or tetracycline: a clinical trial. Scandinavian Journal of Infectious Diseases 27, 2931.
65.Salih, SY and Mustafa, D (1977) Louse-borne relapsing fever: II. Combined penicillin and tetracycline therapy in 160 Sudanese patients. Transactions of the Royal Society of Tropical Medicine and Hygiene 71, 4951.
66.Warrell, DA (1969) Respiratory, Circulatory and Metabolic Disturbances in Relapsing Fever (Dissertation). Oxford, UK: University of Oxford, 246 pp.
67.Remick, DG et al. (1996) Pentoxifylline fails to prevent the Jarisch–Herxheimer reaction or associated cytokine release. Journal of Infectious Diseases 174, 627630.
68.Teklu, B et al. (1983) Meptazinol diminishes the Jarisch–Herxheimer reaction of relapsing fever. Lancet 1, 835839.
69.Wright, DJ (1983) Endogenous opioid withdrawal in the Jarisch–Herxheimer reaction. Lancet 1, 11351136.
70.Fekade, D et al. (1996) Prevention of Jarisch–Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. New England Journal of Medicine 335, 311315.
71.Cooper, PJ et al. (2000) Recombinant human interleukin-10 fails to alter proinflammatory cytokine production or physiologic changes associated with the Jarisch–Herxheimer reaction. Journal of Infectious Diseases 181, 203209.
72.Parry, EH, Bryceson, AD and Leithead, CS (1967) Acute hemodynamic changes during treatment of louse-borne relapsing fever. Lancet 1, 8183.
73.Barker, SC and Barker, D (2019) Killing clothes lice by holding infested clothes away from hosts for 10 days to control louseborne relapsing fever, Bahir Dah, Ethiopia. Emerging Infectious Diseases 25, 304310.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed